ArticleBlood2013
T-cell LPD of the GIT: first do no harm.
Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Untargeted metabolomic analysis in cats with naturally occurring inflammatory bowel disease and alimentary small cell lymphoma.Scientific reports · 2021Article
- Indolent T cell lymphoproliferative disorder of the gastrointestinal tract: an uncommon case with lymph node involvement and the classic Hodgkin's lymphoma.Journal of gastrointestinal oncology · 2020Article
- Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease.BMC veterinary research · 2018Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
In this issue of Blood, Perry et al describe cases of an indolent T-cell lymphoproliferative disorder (LPD) of the gastrointestinal tract (GIT) that mimics inflammatory bowel disease or peripheral T-cell lymphoma (PTCL). The lesions involved all sites in the GIT, and mucosal infiltrates consisted of small lymphoid cells with minimal atypia. The cases were phenotypically heterogeneous but predominantly CD81/CD42, and all had clonal T-cell receptor (TCR) gene rearrangements.
Indexed as
Identifiers
24263952What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.